Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Voss

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Travel Medicine|August 9, 2021
Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: a scoping reviewCarmen Klinger, Jacob Burns, Ani Movsisyan, et al.
Cancer|April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcomaKristina A Cole, Heba Ijaz, Lea F Surrey, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Pediatric Research|January 22, 2005
Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver diseaseIan P J Alwayn, Kathleen Gura, Vânia Nosé, et al.
Journal for Immunotherapy of Cancer|May 18, 2022
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trialJessica Hochberg, Jaclyn Basso, Qiuhu Shi, et al.
Frontiers in Medicine|April 4, 2022
Case Report: A Neuro-Ophthalmological Assessment of Vision Loss in a Pediatric Case of McCune-Albright SyndromeJordan D Lemme, Anthony Tucker-Bartley, Laura A Drubach, et al.
The Lancet. Oncology|March 21, 2020
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trialKara L Davis, Elizabeth Fox, Melinda S Merchant, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Pediatric Blood & Cancer|March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)Emily Greengard, Robin Williams, Branden Moriarity, et al.
BMJ Open|April 10, 2021
Travel-related control measures to contain the COVID-19 pandemic: an evidence mapAni Movsisyan, Jacob Burns, Renke Biallas, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Travel Medicine|August 9, 2021
Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: a scoping reviewCarmen Klinger, Jacob Burns, Ani Movsisyan, et al.
Cancer|April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcomaKristina A Cole, Heba Ijaz, Lea F Surrey, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Pediatric Research|January 22, 2005
Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver diseaseIan P J Alwayn, Kathleen Gura, Vânia Nosé, et al.
Journal for Immunotherapy of Cancer|May 18, 2022
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trialJessica Hochberg, Jaclyn Basso, Qiuhu Shi, et al.
Frontiers in Medicine|April 4, 2022
Case Report: A Neuro-Ophthalmological Assessment of Vision Loss in a Pediatric Case of McCune-Albright SyndromeJordan D Lemme, Anthony Tucker-Bartley, Laura A Drubach, et al.
The Lancet. Oncology|March 21, 2020
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trialKara L Davis, Elizabeth Fox, Melinda S Merchant, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Pediatric Blood & Cancer|March 23, 2024
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)Emily Greengard, Robin Williams, Branden Moriarity, et al.
BMJ Open|April 10, 2021
Travel-related control measures to contain the COVID-19 pandemic: an evidence mapAni Movsisyan, Jacob Burns, Renke Biallas, et al.
Pageof 6